These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 32424573)
1. Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase. Mehta GU; Raza SM; Su SY; Hanna EY; DeMonte F J Neurooncol; 2020 Dec; 150(3):367-375. PubMed ID: 32424573 [TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine and undifferentiated sinonasal and skull base tumors: An up-to-date narrative review. Sideris G; Solomos P; Gogoulos P; Margaris I; Panagoulis E; Vlastarakos P; Karamagkiolas S; Tzagkaroulakis M; Nikolopoulos T; Delides A Oral Maxillofac Surg; 2024 Sep; 28(3):1009-1017. PubMed ID: 38502274 [TBL] [Abstract][Full Text] [Related]
3. Sinonasal Neuroendocrine Neoplasms: Current Challenges and Advances in Diagnosis and Treatment, with a Focus on Olfactory Neuroblastoma. Bell D Head Neck Pathol; 2018 Mar; 12(1):22-30. PubMed ID: 29427030 [TBL] [Abstract][Full Text] [Related]
4. Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment. Jakimovska F; Stojkovski I; Kjosevska E Curr Oncol Rep; 2024 Sep; 26(9):1057-1069. PubMed ID: 38935225 [TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine neoplasms of the sinonasal region. Bell D; Hanna EY; Weber RS; DeMonte F; Triantafyllou A; Lewis JS; Cardesa A; Slootweg PJ; Stenman G; Gnepp DR; Devaney KO; Rodrigo JP; Rinaldo A; Wenig BM; Westra WH; Bishop JA; Hellquist H; Hunt JL; Kusafuka K; Perez-Ordoñez B; Williams MD; Takes RP; Ferlito A Head Neck; 2016 Apr; 38 Suppl 1():E2259-66. PubMed ID: 26041714 [TBL] [Abstract][Full Text] [Related]
6. Proceedings of the 2023 North American Society of Head and Neck Pathology Companion Meeting, New Orleans, LA, March 12, 2023: Navigating New Developments in High Grade Sinonasal Neuroendocrine and Neuroectodermal Neoplasms. Rooper LM Head Neck Pathol; 2023 Jun; 17(2):299-312. PubMed ID: 37184733 [TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine Carcinoma and Sinonasal Undifferentiated Carcinoma. Abdelmeguid AS; Bell D; Hanna EY Adv Otorhinolaryngol; 2020; 84():168-184. PubMed ID: 32731236 [TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine Neoplasms of the Sinonasal Tract: Neuroendocrine Carcinomas and Olfactory Neuroblastoma. Shah K; Perez-Ordóñez B Head Neck Pathol; 2016 Mar; 10(1):85-94. PubMed ID: 26830400 [TBL] [Abstract][Full Text] [Related]
9. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival. Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747 [TBL] [Abstract][Full Text] [Related]
10. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis. Ejaz A; Wenig BM Adv Anat Pathol; 2005 May; 12(3):134-43. PubMed ID: 15900114 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of Epstein-Barr virus infection in sinonasal small round cell tumors. Shinokuma A; Hirakawa N; Tamiya S; Oda Y; Komiyama S; Tsuneyoshi M J Cancer Res Clin Oncol; 2000 Jan; 126(1):12-8. PubMed ID: 10641744 [TBL] [Abstract][Full Text] [Related]
14. Recurrent Wnt Pathway and ARID1A Alterations in Sinonasal Olfactory Carcinoma. Rooper LM; Agaimy A; Bell D; Gagan J; Gallia GL; Jo VY; Lewis JS; London NR; Nishino M; Stoehr R; Thompson LDR; Din NU; Wenig BM; Westra WH; Bishop JA Mod Pathol; 2024 May; 37(5):100448. PubMed ID: 38369189 [TBL] [Abstract][Full Text] [Related]
15. Clinical management of localized undifferentiated sinonasal carcinoma: our experience and review of the literature. Perri F; Della Vittoria Scarpati G; Ionna F; Longo F; Montano M; Muto P; Ravo V; Giuliano M; Caponigro F Anticancer Drugs; 2019 Mar; 30(3):308-312. PubMed ID: 30779722 [TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy. van der Laan TP; Iepsma R; Witjes MJ; van der Laan BF; Plaat BE; Halmos GB Oral Oncol; 2016 Dec; 63():1-9. PubMed ID: 27938993 [TBL] [Abstract][Full Text] [Related]
17. Sinonasal malignancies of neuroendocrine origin. Rischin D; Coleman A Hematol Oncol Clin North Am; 2008 Dec; 22(6):1297-316, xi. PubMed ID: 19010275 [TBL] [Abstract][Full Text] [Related]
18. Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma: differentiation in diagnosis and treatment. Su SY; Bell D; Hanna EY Int Arch Otorhinolaryngol; 2014 Oct; 18(Suppl 2):S149-56. PubMed ID: 25992139 [TBL] [Abstract][Full Text] [Related]
20. Sinonasal Tumors With Neuroepithelial Differentiation (Olfactory Carcinoma): Delineation of Their Pathologic and Clinical Features With Insights into Their Relationship to Olfactory Neuroblastoma and Sinonasal Carcinoma. Rooper LM; Bishop JA; Faquin WC; Foss RD; Gallia GL; Jo VY; Lewis JS; Nishino M; Stelow EB; Thompson LDR; Wenig BM; Westra WH Am J Surg Pathol; 2022 Aug; 46(8):1025-1035. PubMed ID: 35420559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]